We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

ZURICH (Reuters) -Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its ...

The Diabetic Care Devices Market is projected to grow from $16.6 billion in 2024 to $26.8 billion by 2029, at a CAGR of 10.1%. This report provides a comprehensive analysis of diabetes monitoring ...

According to a new market research report titled, 'Cardiac Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

No. 4 / 2025Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

Diabetes describes a group of metabolic diseases characterized by high blood sugar levels. Diabetes can be caused by the pancreas not producing insulin (type 1 diabetes) or by insulin resistance ...

New Tech for Managing Type 1 Diabetes Is Effective for Older Adults Mar. 11, 2025 — New research suggests that automated insulin delivery (AID) systems are safe and effective for use by older ...

Phoenix heat is notorious for the harm it causes in the short-term, like heat stroke and heart problems. Just last year, temperatures there topped 90 degrees Fahrenheit for a record-breaking 188 ...